An Immunohistochemical Study of HIF-1 Alpha in Oral Epithelial Dysplasia and Oral Squamous Cell Carcinoma

  • Nikita Rajendrakumar Patel
  • Leena JainEmail author
  • Aarti Mahendra Mahajan
  • Poonam Vilas Hiray
  • Sandeep S. Shinde
  • Pranjal A. Patel
Original Article


To evaluate and compare the expression of HIF-1 Alpha (HIF-1α) in oral epithelial dysplasia (OED) and various grades of Oral squamous cell carcinoma (OSCC). 30 cases each of OEDand OSCC were stained with HIF-1α antibody. Quantification of HIF-1α positive cellswas carried out and the data was statistically analysed. The mean % HIF-1α labeling index (HIF-1α LI) increased significantly from mild OED (32.11%), moderate OED (55.07%), to severe OED (64.58%). There was a statistically significant increase in the expression of HIF-1α as grades of OED increased. The mean HIF-1α LI % in well differentiated OSCC was 46.3%, Moderately differentiated OSCC—76.31% and Poorly differentiated OSCC—89.9%. The mean HIF-1α LI was found to increase with increasing grades of OSCC which was statistically significant (P < 0.05). Further a comparison of mean HIF-1α LI in OED with different histologic grades of OSCC by Independent samples t test was performed. We found statistically significant difference between OED and moderately differentiated OSCC and OED and poorly differentiated OSCC (P = 0.000). Progressive increase in expression of HIF-1α was noted from OED to OSCC. It can be postulated that epithelial dysplastic lesions with increased HIF-1α expression are at greater risk of malignant transformation, suggesting that the expression of HIF-1α is an early event in oral carcinogenesis.


HIF-1α Oral epithelial dysplasia OSCC Immunohistochemistry 



The present study was not funded by any agency, it was self funded and there was no conflict of interest between authors.

Compliance with Ethical Standards

Conflict of interest

The authors declare that they have no conflict of interest.

Ethical Standards

An Ethical clearance was obtained from the Institutional Ethical Committee. All procedure performed on human participant were in accordance with the ethical standards of the Institutional Ethical Committee.

Informed Consent

Informed consent from patients was obtained prior to examination.


  1. 1.
    Saman DM (2012) A review of the epidemiology of oral and pharyngeal carcinoma: update. Head and Neck Oncology 4:1CrossRefGoogle Scholar
  2. 2.
    Feller L, Lemmer J (2012) Oral squamous cell carcinoma. Journal of Cancer Therapy 3:263–268CrossRefGoogle Scholar
  3. 3.
    Sadiq H, Gupta P, Singh N, Thakar SS, Prabhakar I, Thakral J (2015) Various grading systems of the oral epithelial dysplasia: a review. International Journal of Advanced Health Sciences 1(11):20–26Google Scholar
  4. 4.
    Ishida K, Ito S, Wada N, Deguchi H, Hata T, Hosoda M, Nohno T (2007) Nuclear localization of beta – catenin involved in precancerous change in oral leukoplakia. Molecular Cancer 6:62–68CrossRefGoogle Scholar
  5. 5.
    Scully C, Bagan JV, Hopper C, Epstein JB (2008) Oral cancer: current and future diagnostic techniques. Am J Dent 21:199–209PubMedGoogle Scholar
  6. 6.
    Rohwer N, Cramer T (2011) Hypoxia-mediated drug resistance: novel insights on the functional interaction of HIFs and cell death pathways. Drug Resist Updates 14:191–201CrossRefGoogle Scholar
  7. 7.
    Li JZ, Gao W, Wai Chan JY, Kuen Ho W, Sze Wong T (2012) Hypoxia in head and neck squamous cell carcinoma. ISRN Otolaryngology. 2012:708974CrossRefGoogle Scholar
  8. 8.
    Uehara M, Sano K, Ikeda H, Nonaka M, Asahina I (2009) Hypoxia-inducible factor 1 alpha in oral squamous cell carcinoma and its relation to prognosis. Oral Oncol 45:241–246CrossRefGoogle Scholar
  9. 9.
    Fillies T, Werkmeister R, Van Diest PJ, Brandt B, Joos U, Buerger H (2005) HIF-1 alpha overexpression indicates a good prognosis in early stage squamous cell carcinoma of the oral floor. BMC Cancer 5:84CrossRefGoogle Scholar
  10. 10.
    Santos MD, Cunha Mercante AM, Louro ID, Goncalves AJ, Carvalho MB, Tajara da Silva EH et al (2012) HIF-1 Alpha expression predicts survival of patients with squamous cell carcinoma of the oral cavity. PLoS ONE 7:9Google Scholar
  11. 11.
    Greene FL, Page DL, Fleming ID, Fritz AG, Balch CM, Haller DG et al (2002) AJCC cancer staging manual, 6th edn. Springer, ChicagoCrossRefGoogle Scholar
  12. 12.
    Bryne M, Koppang HS, Lilleng R, Stene T, Bang G, Dabelsteen E (1989) New malignancy grading is a better prognostic indicator than Broder’s grading in oral squamous cell carcinoma. J Oral Pathol Med 18:432–437CrossRefGoogle Scholar
  13. 13.
    Gillenwater A, Papadimitrakopoulou V, Kortum RR (2006) Oral premalignancy: new methods of detection and treatment. Curr Oncol Rep. 8(2):146–154CrossRefGoogle Scholar
  14. 14.
    Dionne KR, Warnakulasuriya S, Zain RB, Cheong S (2015) Potentially malignant disorders of the oral cavity: current practice and future directions in the clinic and laboratory. Int J Cancer 136:503–515PubMedGoogle Scholar
  15. 15.
    Oliveira De Lima P, Jorge CC, Oliveira DT, Pereira MC (2014) Hypoxic condition and prognosis in oral squamous cell carcinoma. Anticancer Res 34:605–612Google Scholar
  16. 16.
    Semenza GL (2010) Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics. Oncogene 29:625–634CrossRefGoogle Scholar
  17. 17.
    Hockel M, Vaupel P (2001) Tumor hypoxia: definitions and current clinical, biologic, and molecular aspects. J Natl Cancer Inst 93:266–276CrossRefGoogle Scholar
  18. 18.
    Chaudhary M, Bajaj S, Bohra S, Swastika N, Hande A (2015) The domino effect: role of hypoxia in malignant transformation of oral submucous fibrosis. Journal of Oral and Maxillofacial Pathology. 19(2):122–127CrossRefGoogle Scholar
  19. 19.
    Lin PY, Yu CH, Wang JT, Chen HH, Cheng SJ, Kuo MYP et al (2008) Expression of hypoxia-inducible factor-1a is significantly associated with the progression and prognosis of oral squamous cell carcinomas in Taiwan. J Oral Pathol Med 37:18–25CrossRefGoogle Scholar
  20. 20.
    Zhou J, Huang S, Wang L, Yuan X, Dong Q, Zhang D et al (2017) Clinical and prognostic significance of HIF-1α overexpression in oral squamous cell carcinoma: a meta-analysis. World J Surg Oncol. 15(1):104CrossRefGoogle Scholar
  21. 21.
    Zhu G, Tang Y, Li L, Zheng M, Jiang J, Li XY et al (2010) Hypoxia inducible factor 1α and hypoxia inducible factor 2α play distinct and functionally overlapping roles in oral squamous cell carcinoma. Clin Cancer Res 16(19):4732–4741CrossRefGoogle Scholar

Copyright information

© Association of Otolaryngologists of India 2019

Authors and Affiliations

  • Nikita Rajendrakumar Patel
    • 1
  • Leena Jain
    • 2
    Email author
  • Aarti Mahendra Mahajan
    • 3
  • Poonam Vilas Hiray
    • 4
  • Sandeep S. Shinde
    • 5
  • Pranjal A. Patel
    • 6
  1. 1.Department of Oral Pathology and MicrobiologySMBT Institute of Dental Sciences and ResearchDhamangaon, NashikIndia
  2. 2.Department of E.N.T.SMBT Institute of Medical Sciences and Research CentreDhamangoan, NashikIndia
  3. 3.Department of Oral Pathology and MicrobiologyMGV’S KBH Dental College and HospitalPanchvati, NashikIndia
  4. 4.Department of Oral Medicine and RadiologySMBT Institute of Dental Sciences and ResearchDhamangoan, NashikIndia
  5. 5.Morya Dental CareNashikIndia
  6. 6.Department of General MedicineSuyash Multispeciality HospitalNashikIndia

Personalised recommendations